Landmark trial
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial
Overgaard J, Hansen HS, Specht L, et al.
DoseLab summary
Randomized trial of five versus six fractions per week of conventionally fractionated radiotherapy for head and neck squamous cell carcinoma. Citation checked against Crossref; content not yet reviewed by DoseLab.
Why this is useful
The Danish trial behind accelerated treatment — six fractions a week to shorten overall treatment time.
Reference details
- Title
- Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial
- Authors / organization
- Overgaard J, Hansen HS, Specht L, et al.
- Publication / protocol
- Lancet. 2003;362(9388):933–940
- Version
- Pending verification
- Year
- 2003
- DOI
- 10.1016/S0140-6736(03)14361-9
- Disease sites
- Head & Neck
- Topics
- Head & Neck, Accelerated fractionation, Landmark trial
- Fractionation context
- 2 Gy fractions, 5 vs 6 fractions per week
- Last reviewed by DoseLab
- Pending verification